Cardiome And Astellas Announce Positive Results From ACT 2 Trial ( NASDAQ: CRME TSX: COM VANCOUVER and DE...)

Cardiome And Astellas Announce Positive Results From ACT 2 Trial

NASDAQ: CRME TSX: COM

VANCOUVER and DEERFIELD, IL, June 04, 2007 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. and its co-development partner Astellas Pharma US, Inc. ("Astellas") today announced results from their recently completed Phase 3 clinical study, called ACT 2. The trial evaluated the efficacy and safety of the intravenous formulation of vernakalant hydrochloride ("vernakalant (iv)") for the treatment of patients who developed atrial fibrillation or atrial flutter between 24 hours and 7 days following coronary artery bypass graft (CABG) or valve replacement surgery. In the atrial fibrillation population, 47% of patients dosed with vernakalant (iv) experienced conversion to normal heart rhythm within 90 minutes, as compared to 14% of placebo patients, a statistically significant difference (p=0.0001).

The ACT 2 study data suggests that vernakalant (iv) was well-tolerated in the studied patient population. In the 30-day interval following drug administration, serious adverse events occurred in 9% of all patients dosed with vernakalant (iv) and 11% of all placebo patients. Potentially drug-related serious adverse events occurred in 2% of patients who received vernakalant (iv) and 0% of placebo patients. There were no cases of drug-related "Torsades de Pointes", a specific and well-characterized ventricular arrhythmia.

The study achieved its primary endpoint in the combined atrial fibrillation and atrial flutter groups, showing that 45% of patients receiving vernakalant (iv) converted to normal heart rhythm within 90 minutes, as compared to 15% of placebo patients within the same time period (p=0.0002). Of the 10 patients in the atrial flutter population, no patients in the drug group and one patient in the placebo group converted to normal heart rhythm. A total of 190 patients were randomized in the study, of which 161 received treatment.

In the patients treated with vernakalant (iv
'"/>

Page: 1 2 3 4 5 6
Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:

(Date:5/23/2013)... 23, 2013 The need to add tissue ... was highlighted prominently at the 108 th ... in San Diego. According to SonaCare Medical, a ... (HIFU) technology, the need for image-guided technologies to ... to consider minimally invasive ablative treatments, was addressed ...

(Date:5/23/2013)... -- Texas, premier physician associations today announced the establishment of ... need to provide demonstrably better and more efficient patient ... "I am confident the Physician Services Organization for ... Stephen L. Brotherton , MD, president of the ... doctors are determined to make health care better and ...

(Date:5/23/2013)... May 23, 2013 Direct to implant, ... is an appropriate option for many women with ... reduce their breast cancer risk, or with breast ... process and a second surgery to insert permanent ... same surgery as mastectomy can be a medically ...

Breaking Medicine Technology:Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5 Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6 TMA Launches Physician Services Organization for Patient Care 2 TMA Launches Physician Services Organization for Patient Care 3 TMA Launches Physician Services Organization for Patient Care 4 Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2 Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3

[0] Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting [0] TMA Launches Physician Services Organization for Patient Care [0] Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results

... LAUDERDALE, Fla., Sept. 23 OmniComm Systems, Inc. ... in the EDC marketplace, today announced that Beardsworth, ... specializes in difficult therapeutic areas, has selected OmniComm,s ... process. AE Reporting is an advanced adverse event ...

... According to Millennium Research Group (MRG), the ... physicians will increasingly adopt abdominal and thoracic endovascular aortic ... awareness of the benefits of endovascular techniques grows and ... tends to be a slightly more attractive option for ...

Cached Medicine Technology:Beardsworth® Selects OmniComm Systems® AE Reporting System 2 Beardsworth® Selects OmniComm Systems® AE Reporting System 3 Latin American Aortic Stent Graft Market to Reach Over $150 Million by 2015, According to Millennium Research Group 2

Beardsworth® Selects OmniComm Systems® AE Reporting System Latin American Aortic Stent Graft Market to Reach Over $150 Million by 2015, According to Millennium Research Group

(Date:5/24/2013)... 2013 BestSatelliteProviders.com the online satellite ... of consumers compare the features and services offered ... recently released the rankings of the best ... for viewing on their website. , ... to Adam Matthews, the spokesperson for BestSatelliteProviders.com, “When ...

(Date:5/24/2013)... -- People with high levels of cadmium in their ... disease than those with lower levels, a new study ... is evidence of long-term exposure to the heavy metal ... the Johns Hopkins researchers explained. They also said ... liver disease but instead suggest an association that requires ...

(Date:5/24/2013)... 6Webs.com has educated thousands of buyers ... home security monitoring provider. The easy to read ... resource consumers prefer for unbiased and impartial home security ... the leading wireless home security system providers in the ... a number of key factors including reliability, technology and ...

(Date:5/24/2013)... According to a May 15, 2013 Time ... to Spikes in Plastic Surgery Requests,” a number ... of facial plastic surgery and cosmetic improvements among ... keenly aware of the need to look good online and ... and even Skype's video chat feature (Go to goo.gl/WO0PR). , ...

(Date:5/24/2013)... (PRWEB) May 24, 2013 American Career ... education community, proudly participated in festivities surrounding the 2013 ... The event provided the perfect backdrop to introduce the ... 236 E. 3rd Street, housed in an architectural gem ... , ACC was an active exhibitor throughout the weekend ...

Breaking Medicine News(10 mins):Health News:Best Rural Internet Service Provider in 2013 by BestSatelliteProviders.com 2 Health News:High Cadmium Levels May Raise Risk for Dying From Liver Disease: Study 2 Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2 Health News:Facebook and Google – Is Social Media Driving Demand for Plastic Surgery? 2 Health News:American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach 2

[0] Best Rural Internet Service Provider in 2013 by BestSatelliteProviders.com [0] High Cadmium Levels May Raise Risk for Dying From Liver Disease: Study [0] 2013 Best Wireless Security System Providers Reported by 6Webs.com [0] Facebook and Google – Is Social Media Driving Demand for Plastic Surgery?[0] American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach

... , NEW YORK, Sept. ... research report is available in its catalogue. , ... Opportunities Post-Launch: Contract Manufacturing and Contract Sales and ... http://www.reportlinker.com/p099450/Pharmaceutical-Outsourcing-Opportunities-Post-Launch-Contract-Manufacturing-and-Contract-Sales-and-Marketing-3rd-Edition.html , , ...

... NEW YORK, Sept. 22 Reportlinker.com announces that a new market research ... Medical Beds and Medical Chairs , , ... , This report provides the reader with an overview ... growth. Medical beds include all hospital types of beds including mattresses and ...

... , , , , ... released the "100 Best Companies for Working Mothers" list and this marks ... , , "SC Johnson is pleased to be honored ... of SC Johnson. "Treating our people with respect, integrity and fairness is ...

... , PETERSBURG, Va., Sept. 22 ... of low-nitrosamine smokeless tobacco products, announced today that the company ... preparation of tobacco to formulate dissolvable smokeless tobacco products. This ... filed in December, 2008. Its use has resulted in tobacco ...

... RICHMOND, Va., Sept. 22 Defying expectations in this time ... among the Top Ten 2009 Working Mother 100 Best Companies ... named to Working Mother ,s prestigious list consecutively since 1999, earning ... , , "Being recognized as a Top Ten employer ...

... ... iPhone™ Application Developed by Dr. Richard Bandler , ... Köping, Sweden (Vocus) — Hästens, the luxury bed maker ... for the iPhone™ and iPod Touch™, the most recent technological extension of the company’s ...

Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 3rd Edition Report Reportlinker Adds Medical Beds and Medical Chairs Report SC Johnson a Best Company for Working Moms Star Scientific Breaks New Ground, Plans FDA Filing for Approval of First 'Modified Risk' Tobacco Product; Nominates Curtis Wright, MD, MPH for FDA Advisory Committee Bon Secours Richmond Named A Top Ten 2009 Working Mother 100 Best Company Luxury Bed Maker Hstens Introduces Mindspa iPhone™ Application

The Stryker CBCII Blood Conservation System provides a safe, simple and economic disposable system for blood reinfusion....

... is a bioresorbable implant that is used ... This proprietary, user-friendly design, shaped like ... fit into burr holes and requires no ... has superior mechanical strength and the scaffold ...

The S4 Spinal System has quickly gained a reputation for being the next generation in pedicle screw systems because of its exceptionally small size and high biomechanical strength....

... RESTOREADVANCED is a rechargeable neurostimulator equipped with ... battery has a 9-year FDA approved battery ... on the market. This is helpful to ... their pain. What makes RESTOREADVANCED and PRIMEADVANCED ...

Medicine Products:

ConstaVac CBCII Blood Conservation System Osteoplug Bioresorbable Implant for Trephination Burr Holes S4 Spinal System RESTOREADVANCED Neurostimulator